Graphique du cours de l'action AKESF
AKESF Gagner
Akeso, Inc.
$11.13
-8.3%
$-1
À la fermeture : Sep 02, 16:00:00 GMT-4
$11.5
3.32%
$0.36
Post-Marché: Sep 02, 19:59:59 GMT-4
Retour
Akeso, Inc. (AKESF) Gagner
Statistiques clés
Clôture préc.
$12.13
Prix d'ouverture
$11.5
Plage de la journée
$11.19 - $11.5
Plage de 52 semaines
$10.5 - $21.35
Volume
300
Volume moyen
1.5K
Rendement en dividend
--
BPA (TTM)
-0.16
Capitalisation boursière
$10.5B
Qu’est-ce que AKESO INC. ?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company employs 3,761 full-time employees The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
Fonctionnalités
© 2026 Edgen fonctionné par